Abstract
P-164 Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLƐ)-mutated solid tumours in the GARNET study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have